Search Results - "Walz, Johanna M"

Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders by Walz, Johanna M, Boehringer, Daniel, Deissler, Heidrun L, Faerber, Lothar, Goepfert, Jens C, Heiduschka, Peter, Kleeberger, Susannah M, Klettner, Alexa, Krohne, Tim U, Schneiderhan-Marra, Nicole, Ziemssen, Focke, Stahl, Andreas

“…Vascular endothelial growth factor-A (VEGF-A) is intensively investigated in various medical fields. However, comparing VEGF-A measurements is difficult…”
Get full text

The German ROP Registry: data from 90 infants treated for retinopathy of prematurity by Walz, Johanna M., Bemme, Sebastian, Pielen, Amelie, Aisenbrey, Sabine, Breuß, Helge, Alex, Anne F., Wagenfeld, Lars, Schiedel, Susanne, Krohne, Tim U., Stahl, Andreas, Akman, Stella H., Bajor, Anna, Biermann, Julia, Bohnhorst, Bettina, Brockmann, Dorothee, Diehl, Thilo Alexander, Eter, Nicole, Feltgen, Nicolas, Framme, Carsten, Gesser, Caroline, Gross, Nikolai, Hagemann, Ulrike, Hentschel, Roland, Holz, Frank G., Hufendiek, Karsten, Kracht, Thorben, Küster, Helmut, Lagreze, Wolf, Lakshminarasimhan, Maya, Lazer, Nils, Limburg, Endrik, Mueller, Andreas, Partsch, Michael, Pfeiffer, Andrea, Pham, Duy‐Thoai, Rabenau, Jana, Reichl, Sabine, Schönbeck, Marco, Schrader, Merle, Stavropoulou, Dimitra, Stech, Milena, Stemplewitz, Birthe, Süsskind, Daniela, Tautz, Juliane, Völker, Michael, Wolf, Monika Anna

“…Purpose The German retinopathy of prematurity (ROP) Registry collects data on treated ROP in a multicentre approach to analyse epidemiology and treatment…”
Get full text

Sema3f Protects Against Subretinal Neovascularization In Vivo by Sun, Ye, Liegl, Raffael, Gong, Yan, Bühler, Anima, Cakir, Bertan, Meng, Steven S., Burnim, Samuel B., Liu, Chi-Hsiu, Reuer, Tristan, Zhang, Peipei, Walz, Johanna M., Ludwig, Franziska, Lange, Clemens, Agostini, Hansjürgen, Böhringer, Daniel, Schlunck, Günther, Smith, Lois E.H., Stahl, Andreas

“…Pathological neovascularization of the outer retina is the hallmark of neovascular age-related macular degeneration (nAMD). Building on our previous…”
Get full text

Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial by Stahl, Andreas, Krohne, Tim U, Eter, Nicole, Oberacher-Velten, Isabel, Guthoff, Rainer, Meltendorf, Synke, Ehrt, Oliver, Aisenbrey, Sabine, Roider, Johann, Gerding, Heinrich, Jandeck, Claudia, Smith, Lois E H, Walz, Johanna M

“…Anti-vascular endothelial growth factor (VEGF) therapies are a novel treatment option in retinopathy of prematurity (ROP). Data on dosing, efficacy, and safety…”
Get more information

Impact of angiogenic activation and inhibition on miRNA profiles of human retinal endothelial cells by Walz, Johanna M., Wecker, Thomas, Zhang, Pei Pei, Cakir, Bertan, Gruening, Bjoern, Agostini, Hansjuergen, Reuer, Tristan, Ludwig, Franziska, Boneva, Stefaniya, Faerber, Lothar, Lange, Clemens, Schlunck, Guenther R., Stahl, Andreas

“…Human retinal microvascular endothelial cells (HRMVECs) are involved in the pathogenesis of retinopathy of prematurity. In this study, the microRNA (miRNA)…”
Get full text

CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy by Bucher, Felicitas, Walz, Johanna M, Bühler, Anima, Aguilar, Edith, Lange, Clemens, Diaz-Aguilar, Sophia, Martin, Gottfried, Schlunck, Günther, Agostini, Hansjürgen, Friedlander, Martin, Stahl, Andreas

“…Retinal vascular disease represents a major cause for vision loss in the Western world. Recent research has shown that neuronal and vascular damage are closely…”
Get full text

Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival by Reuer, Tristan, Schneider, Ann-Charlott, Cakir, Bertan, Bühler, Anima D, Walz, Johanna M, Lapp, Thabo, Lange, Clemens, Agostini, Hansjürgen, Schlunck, Günther, Cursiefen, Claus, Reinhard, Thomas, Bock, Felix, Stahl, Andreas

“…Corneal vascularization significantly increases the risk for graft rejection after keratoplasty. Semaphorin 3F (Sema3F) is a known modulator of physiologic…”
Get full text

Parental views on the principles for cluster randomised trials involving neonates and infants by Thiele, Nicole, Walz, Johanna M., Lindacher, Verena, Mader, Silke, Greisen, Gorm, Bonnard, Livia Nagy, Daly, Mandy, Guerra, Paula, Makaruk, Tomasz, Steenbrugge, Gert, Vavouraki, Eleni, Verhaest, Yannic, Virchez, Mónica

Get full text

Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival by Reuer, Tristan, Schneider, Ann-Charlott, Cakir, Bertan, Bühler, Anima D., Walz, Johanna M., Lapp, Thabo, Lange, Clemens, Agostini, Hansjürgen, Schlunck, Günther, Cursiefen, Claus, Reinhard, Thomas, Bock, Felix, Stahl, Andreas

Get full text

Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders: e0145375 by Walz, Johanna M, Boehringer, Daniel, Deissler, Heidrun L, Faerber, Lothar, Goepfert, Jens C, Heiduschka, Peter, Kleeberger, Susannah M, Klettner, Alexa, Krohne, Tim U, Schneiderhan-Marra, Nicole

“…Background Vascular endothelial growth factor-A (VEGF-A) is intensively investigated in various medical fields. However, comparing VEGF-A measurements is…”
Get full text